Treatments & Interventions
Tocopherol
substance
Vitamin E and/or vitamin E derivative-containing product
product
Amantadine hydrochloride
substance
Amantadine
substance
Alpha tocopherol acetate
substance
Amantadine sulfate
substance
Alpha tocopherol succinate
substance
Deutetrabenazine
substance
Valbenazine
substance
dl-alpha-tocopherol
substance
dl-alpha-tocopheryl acetate
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Akathisia
HP:0031943
Tardive dyskinesia
HP:0040141
Quick Facts
- SNOMED CT
- 38941006
- UMLS CUI
- C0543891
- Fully Specified Name
- Neuroleptic-induced tardive dyskinesia (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 2
- Known Treatments
- 11
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.